The revised cardiac risk index and 90-day mortality after non-cardiac surgery: a retrospective cohort study - Top-Institutions - MDSpire

The revised cardiac risk index and 90-day mortality after non-cardiac surgery: a retrospective cohort study

  • By

  • Guangqin Ren

  • Qing Xie

  • Xue Guo

  • Guanglin Sang

  • Danqing Ren

  • Zhiwei Li

  • Xiangmei Tan

  • Huibing Chen

  • Yang Song

  • Lijuan Dong

  • July 15, 2026

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    SingHealth Centralised Institutional Review Board
    SingHealth Centralised Institutional Review Board

    Singapore, Singapore

    Key Differentiators

    • Cardiology

  • #2

    Danish Colorectal Cancer Group
    Danish Colorectal Cancer Group

    Copenhagen, Denmark

    Key Differentiators

    • Colorectal Surgery

  • #3

    University Hospital of Heidelberg
    University Hospital of Heidelberg

    Heidelberg, Germany

    Key Differentiators

    • Cardiology

  • #4

    Nanfang Hospital, Southern Medical University
    Nanfang Hospital, Southern Medical University

    Guangzhou, China

    Key Differentiators

    • Thoracic Surgery

  • #5

    Heart and Diabetes Center NRW
    Heart and Diabetes Center NRW

    Bad Oeynhausen, Germany

    Key Differentiators

    • Cardiology

Original Source(s)

The revised cardiac risk index and 90-day mortality after non-cardiac surgery: a retrospective cohort study

  • by Guangqin Ren, Qing Xie, Xue Guo, Guanglin Sang, Danqing Ren, Zhiwei Li, Xiangmei Tan, Huibing Chen, Yang Song, Lijuan Dong

  • July 15, 2026

Related Content

Seasonal patterns in diagnosis of coronary artery disease by CT-angiography—experience from a large real-world cohort

Toll-like receptors in infectious myocarditis: pathogen-specific recognition, spatiotemporal dynamic regulation and clinical translation

CGM Linked to More Time in Range

In a randomized crossover trial of insulin-treated patients receiving hemodialysis, real-time continuous glucose monitoring did not improve the primary hypoglycemia outcome but increased time in range and reduced time above range vs capillary testing.